The present study suggests that some cancer subtypes may be more responsive than others, since, for example, MMP3 expression was significantly prognostic of outcome in lung adenocarcinoma but not in squamous cell carcinoma; further studies to validate our observations in additional clinical cohorts of breast, lung, and pancreatic cancers are warranted. This evidence concerns the gene MMP3 and pancreatic neoplasm.